Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis.

Dialysis related amyloidosis (DRA) is a major complication of long term hemodialysis therapy. It is well recognized that scintigraphic study using radioisotope-labeled beta 2-microglobulin (beta 2M) as a tracer is a sensitive and specific technique to diagnose DRA non-invasively. The aim of this study is to clarify the mechanism of 131I-beta 2M accumulation around the amyloid tissue. Three dialysis patients with carpal tunnel syndromes were examined for consecutive 131I-beta 2M scintigraphies every 24 hours for 3 days till the carpal tunnel synovectomy. Removed synovial tissues were processed for histological study. The scintigraphic study demonstrated tracer accumulations in the joints involved with DRA and the intensity increased in a time dependent fashion. Microscopic observations revealed many inflammatory cells presenting CD68-monocytes/macrophages antigen infiltrated into the synovial tissues. 131I-beta 2M was evident in the cytoplasm of the infiltrating cells, while no radioactivity was detected above background in the amyloid tissues. In conclusion, the tracer accumulations observed in the 131I-beta 2M scintigraphic studies were the consequence of circulating beta 2M assimilated by the infiltrating monocytes/macrophages. Thus, the undetermined elimination pathway of circulating beta 2M in the dialysis patients was identified as the storage pool in those inflammatory cells. The inflammatory change may play a crucial role in the local progression of DRA through the accumulation of circulating beta 2M around the established amyloid tissues.

[1]  M. Skinner,et al.  Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. , 1996, Kidney international.

[2]  T. Miyazaki,et al.  Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosis , 1996 .

[3]  M. Jadoul,et al.  Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  T. Miyazaki,et al.  Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. , 1996, Kidney international.

[5]  F. Gejyo,et al.  131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis. , 1995, Clinical nephrology.

[6]  T. Miyazaki,et al.  Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. , 1995, Kidney international.

[7]  R. Kuwano,et al.  Histocytochemical study of Spot 35‐calbindin‐D28K and Ca2+‐ATPase in rat kidney , 1995 .

[8]  M. Brownlee,et al.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. , 1994, The Journal of clinical investigation.

[9]  M. Brownlee.  Glycation and Diabetic Complications , 1994, Diabetes.

[10]  H. Seo,et al.  Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. , 1994, The Journal of clinical investigation.

[11]  F. Gejyo,et al.  Application of confocal laser scanning microscopy to the observation of bone biopsy specimens. , 1993, Bone.

[12]  N. Taniguchi,et al.  beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. , 1993, The Journal of clinical investigation.

[13]  O. Toupance,et al.  Beta 2-microglobulin metabolism in uremic patients who are undergoing dialysis. , 1993, Kidney international. Supplement.

[14]  F. Gejyo,et al.  Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis. , 1993, Kidney international. Supplement.

[15]  J. Chanard,et al.  Kinetics of 125I-β2-microglobulin turnover in dialyzed patients , 1992 .

[16]  K. Ohashi,et al.  Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column. , 1992, Kidney international.

[17]  K. Koch,et al.  Dialysis-related amyloidosis. , 1992, Kidney international.

[18]  M. Pepys,et al.  Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component , 1991, The Lancet.

[19]  W. Burchert,et al.  Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin. , 1990, Kidney international.

[20]  E. Ritz,et al.  Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. , 1989, Kidney international.

[21]  J. Coburn,et al.  Amyloid syndromes associated with hemodialysis. , 1989, Kidney international.

[22]  D. Sethi,et al.  Synovial-fluid beta 2-microglobulin levels in dialysis arthropathy. , 1986, The New England journal of medicine.

[23]  M Arakawa,et al.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.

[24]  R. Coombes,et al.  LOCATION OF METASTATIC BREAST CARCINOMA BY A MONOCLONAL ANTIBODY CHELATE LABELLED WITH INDIUM-111 , 1983, The Lancet.

[25]  J. Revillard,et al.  Turnover studies of human beta 2-microglobulin in the rat: evidence for a beta 2-microglobulin-binding plasma protein. , 1982, Clinical science.

[26]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[27]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[28]  J. Floege,et al.  Beta-2-microglobulin-associated amyloidosis. , 1996, Nephron.

[29]  F. Gejyo,et al.  Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis. , 1995, Contributions to Nephrology.

[30]  P. Kerr,et al.  Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.